Literature DB >> 31096043

Bioprinting of stem cell expansion lattices.

Christopher D Lindsay1, Julien G Roth2, Bauer L LeSavage3, Sarah C Heilshorn4.   

Abstract

Stem cells have great potential in regenerative medicine, with neural progenitor cells (NPCs) being developed as a therapy for many central nervous system diseases and injuries. However, one limitation to the clinical translation of stem cells is the resource-intensive, two-dimensional culture protocols required for biomanufacturing a clinically-relevant number of cells. This challenge can be overcome in an easy-to-produce and cost-effective 3D platform by bioprinting NPCs in a layered lattice structure. Here we demonstrate that alginate biopolymers are an ideal bioink for expansion lattices and do not require chemical modifications for effective NPC expansion. Alginate bioinks that are lightly crosslinked prior to printing can shield printed NPCs from potential mechanical damage caused by printing. NPCs within alginate expansion lattices remain in a stem-like state while undergoing a 2.5-fold expansion. Importantly, we demonstrate the ability to efficiently remove NPCs from printed lattices for future down-stream use as a cell-based therapy. These results demonstrate that 3D bioprinting of alginate expansion lattices is a viable and economical platform for NPC expansion that could be translated to clinical applications.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  3D bioprinting; Biofabrication; Cell manufacturing

Mesh:

Substances:

Year:  2019        PMID: 31096043      PMCID: PMC7050497          DOI: 10.1016/j.actbio.2019.05.014

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  39 in total

1.  Neural stem cell heterogeneity demonstrated by molecular phenotyping of clonal neurospheres.

Authors:  Oleg N Suslov; Valery G Kukekov; Tatyana N Ignatova; Dennis A Steindler
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-15       Impact factor: 11.205

2.  Neurosphere and neurosphere-forming cells: morphological and ultrastructural characterization.

Authors:  Alessandra Bez; Elena Corsini; Daniela Curti; Marco Biggiogera; Augusto Colombo; Roberto Francesco Nicosia; Stefano Filippo Pagano; Eugenio Agostino Parati
Journal:  Brain Res       Date:  2003-12-12       Impact factor: 3.252

Review 3.  Strengths and limitations of the neurosphere culture system.

Authors:  Josephine B Jensen; Malin Parmar
Journal:  Mol Neurobiol       Date:  2006-12       Impact factor: 5.590

Review 4.  The systematic production of cells for cell therapies.

Authors:  Daniel C Kirouac; Peter W Zandstra
Journal:  Cell Stem Cell       Date:  2008-10-09       Impact factor: 24.633

5.  Human Neural Stem Cell Transplantation in Chronic Cervical Spinal Cord Injury: Functional Outcomes at 12 Months in a Phase II Clinical Trial.

Authors:  George M Ghobrial; Kim D Anderson; Marine Dididze; Jasmine Martinez-Barrizonte; Gabriel H Sunn; Katie L Gant; Allan D Levi
Journal:  Neurosurgery       Date:  2017-09-01       Impact factor: 4.654

Review 6.  Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeutics.

Authors:  Kevin G Chen; Barbara S Mallon; Ronald D G McKay; Pamela G Robey
Journal:  Cell Stem Cell       Date:  2014-01-02       Impact factor: 24.633

7.  3D in vitro bioengineered tumors based on collagen I hydrogels.

Authors:  Christopher S Szot; Cara F Buchanan; Joseph W Freeman; Marissa N Rylander
Journal:  Biomaterials       Date:  2011-07-22       Impact factor: 12.479

8.  Hydrogel substrate stress-relaxation regulates the spreading and proliferation of mouse myoblasts.

Authors:  Aline Bauer; Luo Gu; Brian Kwee; Weiwei Aileen Li; Maxence Dellacherie; Adam D Celiz; David J Mooney
Journal:  Acta Biomater       Date:  2017-08-30       Impact factor: 8.947

9.  Preclinical Efficacy Failure of Human CNS-Derived Stem Cells for Use in the Pathway Study of Cervical Spinal Cord Injury.

Authors:  Aileen J Anderson; Katja M Piltti; Mitra J Hooshmand; Rebecca A Nishi; Brian J Cummings
Journal:  Stem Cell Reports       Date:  2017-02-14       Impact factor: 7.765

10.  Hydrogels with tunable stress relaxation regulate stem cell fate and activity.

Authors:  Ovijit Chaudhuri; Luo Gu; Darinka Klumpers; Max Darnell; Sidi A Bencherif; James C Weaver; Nathaniel Huebsch; Hong-Pyo Lee; Evi Lippens; Georg N Duda; David J Mooney
Journal:  Nat Mater       Date:  2015-11-30       Impact factor: 43.841

View more
  6 in total

Review 1.  3D Bioprinting of Cell-Laden Hydrogels for Improved Biological Functionality.

Authors:  Sarah M Hull; Lucia G Brunel; Sarah C Heilshorn
Journal:  Adv Mater       Date:  2021-10-20       Impact factor: 30.849

Review 2.  Hydrogels for Tissue Engineering: Addressing Key Design Needs Toward Clinical Translation.

Authors:  Fei Xu; Chloe Dawson; Makenzie Lamb; Eva Mueller; Evan Stefanek; Mohsen Akbari; Todd Hoare
Journal:  Front Bioeng Biotechnol       Date:  2022-05-05

3.  Emergence of FRESH 3D printing as a platform for advanced tissue biofabrication.

Authors:  Daniel J Shiwarski; Andrew R Hudson; Joshua W Tashman; Adam W Feinberg
Journal:  APL Bioeng       Date:  2021-02-16

4.  3D Bioprinting using UNIversal Orthogonal Network (UNION) Bioinks.

Authors:  Sarah M Hull; Christopher D Lindsay; Lucia G Brunel; Daniel J Shiwarski; Joshua W Tashman; Julien G Roth; David Myung; Adam W Feinberg; Sarah C Heilshorn
Journal:  Adv Funct Mater       Date:  2020-11-20       Impact factor: 18.808

5.  Bioprinting Cell- and Spheroid-Laden Protein-Engineered Hydrogels as Tissue-on-Chip Platforms.

Authors:  Daniela F Duarte Campos; Christopher D Lindsay; Julien G Roth; Bauer L LeSavage; Alexis J Seymour; Brad A Krajina; Ricardo Ribeiro; Pedro F Costa; Andreas Blaeser; Sarah C Heilshorn
Journal:  Front Bioeng Biotechnol       Date:  2020-04-28

Review 6.  Biomaterials Based on Marine Resources for 3D Bioprinting Applications.

Authors:  Yi Zhang; Dezhi Zhou; Jianwei Chen; Xiuxiu Zhang; Xinda Li; Wenxiang Zhao; Tao Xu
Journal:  Mar Drugs       Date:  2019-09-28       Impact factor: 5.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.